Ｖｅｒｉｔａｓ Ｉｎ Ｓｉｌｉｃｏの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/23 | 1,670 | 1,716 | 1,635 | 1,693 | +23 | +1.4% | 12,500 |
| 2024/04/22 | 1,625 | 1,670 | 1,585 | 1,670 | +50 | +3.1% | 15,300 |
| 2024/04/19 | 1,652 | 1,666 | 1,600 | 1,620 | -49 | -2.9% | 35,800 |
| 2024/04/18 | 1,650 | 1,686 | 1,620 | 1,669 | +19 | +1.2% | 18,200 |
| 2024/04/17 | 1,701 | 1,730 | 1,650 | 1,650 | -59 | -3.5% | 36,100 |
| 2024/04/16 | 1,746 | 1,789 | 1,688 | 1,709 | -37 | -2.1% | 30,500 |
| 2024/04/15 | 1,660 | 1,750 | 1,657 | 1,746 | +46 | +2.7% | 28,700 |
| 2024/04/12 | 1,791 | 1,825 | 1,700 | 1,700 | -91 | -5.1% | 30,800 |
| 2024/04/11 | 1,847 | 1,847 | 1,770 | 1,791 | -29 | -1.6% | 23,700 |
| 2024/04/10 | 1,750 | 1,820 | 1,690 | 1,820 | +70 | +4% | 54,700 |
| 2024/04/09 | 1,814 | 1,878 | 1,744 | 1,750 | -87 | -4.7% | 57,700 |
| 2024/04/08 | 1,850 | 2,000 | 1,825 | 1,837 | +64 | +3.6% | 106,400 |
| 2024/04/05 | 1,670 | 1,814 | 1,640 | 1,773 | +92 | +5.5% | 120,700 |
| 2024/04/04 | 1,820 | 1,864 | 1,681 | 1,681 | -138 | -7.6% | 110,200 |
| 2024/04/03 | 1,930 | 1,954 | 1,819 | 1,819 | -142 | -7.2% | 91,400 |
| 2024/04/02 | 2,161 | 2,259 | 1,941 | 1,961 | -173 | -8.1% | 247,400 |
| 2024/04/01 | 2,023 | 2,330 | 2,023 | 2,134 | +151 | +7.6% | 436,300 |
| 2024/03/29 | 1,851 | 2,200 | 1,835 | 1,983 | +160 | +8.8% | 356,800 |
| 2024/03/28 | 1,891 | 1,900 | 1,809 | 1,823 | -87 | -4.6% | 71,500 |
| 2024/03/27 | 2,000 | 2,000 | 1,831 | 1,910 | -105 | -5.2% | 294,600 |
| 2024/03/26 | 1,701 | 2,015 | 1,661 | 2,015 | +400 | +24.8% | 572,200 |
| 2024/03/25 | 1,671 | 1,717 | 1,590 | 1,615 | -45 | -2.7% | 71,000 |
| 2024/03/22 | 1,534 | 1,660 | 1,470 | 1,660 | +117 | +7.6% | 160,800 |
| 2024/03/21 | 1,700 | 1,720 | 1,540 | 1,543 | -78 | -4.8% | 147,900 |
| 2024/03/19 | 1,645 | 1,756 | 1,615 | 1,621 | -9 | -0.6% | 75,500 |
| 2024/03/18 | 1,621 | 1,710 | 1,598 | 1,630 | -42 | -2.5% | 63,700 |
| 2024/03/15 | 1,764 | 1,770 | 1,567 | 1,672 | -118 | -6.6% | 188,700 |
| 2024/03/14 | 1,818 | 1,858 | 1,756 | 1,790 | -68 | -3.7% | 68,600 |
| 2024/03/13 | 1,901 | 1,977 | 1,809 | 1,858 | -67 | -3.5% | 71,600 |
| 2024/03/12 | 1,701 | 1,980 | 1,686 | 1,925 | +217 | +12.7% | 207,300 |
| 2024/03/11 | 2,000 | 2,005 | 1,651 | 1,708 | -397 | -18.9% | 311,800 |
| 2024/03/08 | 2,240 | 2,280 | 2,082 | 2,105 | -85 | -3.9% | 89,900 |
| 2024/03/07 | 2,422 | 2,448 | 2,136 | 2,190 | -82 | -3.6% | 212,200 |
| 2024/03/06 | 2,060 | 2,326 | 2,019 | 2,272 | +212 | +10.3% | 219,800 |
| 2024/03/05 | 2,132 | 2,192 | 2,001 | 2,060 | -12 | -0.6% | 192,500 |
| 2024/03/04 | 2,093 | 2,155 | 2,020 | 2,072 | -21 | -1% | 95,300 |
| 2024/03/01 | 2,220 | 2,260 | 2,000 | 2,093 | -161 | -7.1% | 246,300 |
| 2024/02/29 | 2,274 | 2,363 | 2,238 | 2,254 | -61 | -2.6% | 79,700 |
| 2024/02/28 | 2,285 | 2,390 | 2,207 | 2,315 | -41 | -1.7% | 301,700 |
| 2024/02/27 | 2,510 | 2,560 | 2,356 | 2,356 | -185 | -7.3% | 255,200 |
| 2024/02/26 | 2,543 | 2,715 | 2,528 | 2,541 | +13 | +0.5% | 472,600 |
| 2024/02/22 | 2,717 | 2,870 | 2,500 | 2,528 | -236 | -8.5% | 819,900 |
| 2024/02/21 | 2,751 | 3,060 | 2,736 | 2,764 | -67 | -2.4% | 2,277,100 |
| 2024/02/20 | 3,120 | 3,250 | 2,772 | 2,831 | -214 | -7% | 5,355,700 |
| 2024/02/19 | 2,481 | 3,045 | 2,307 | 3,045 | +504 | +19.8% | 4,932,200 |
| 2024/02/16 | 2,641 | 2,720 | 2,502 | 2,541 | -169 | -6.2% | 605,200 |
| 2024/02/15 | 3,340 | 3,475 | 2,549 | 2,710 | -465 | -14.6% | 3,385,800 |
| 2024/02/14 | 3,025 | 3,175 | 2,970 | 3,175 | +502 | +18.8% | 933,800 |
| 2024/02/13 | 3,285 | 3,355 | 2,606 | 2,673 | -332 | -11% | 3,761,900 |
| 2024/02/09 | 2,851 | 3,005 | 2,606 | 3,005 | +504 | +20.2% | 5,396,100 |
251～
300
件表示中 / 301件
類似銘柄と比較する
現在ご覧いただいている「ＶＩＳ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＶＩＳ | 67,300円 | +306.2% | - | 0.00% | 25.98倍 | 1.98倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
| ＤＥＬＴＡ－Ｐ | 45,600円 | - | - | 0.00% | - | 14.13倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
| 免疫生物 | 47,400円 | +13.4% | +44.0% | 0.00% | 20.54倍 | 3.30倍 |
|
研究用試薬の製販・受託。遺伝子組み換えカイコの基礎研究は休止し、化粧品等応用開発に移行 |
| リボミック | 8,800円 | - | - | 0.00% | - | 1.19倍 |
|
東大発の創薬ベンチャー。ＲＮＡ（リボ核酸）を利用した分子標的薬（アプタマー医薬）を開発 |
| 室町ケミカル | 88,400円 | +5.2% | +0.5% | 2.83% | 11.80倍 | 1.52倍 |
|
医薬品原薬の販売・製造、健康食品の企画・製造や、液体処理用イオン交換樹脂等の化学品も展開 |
市場注目の銘柄
チャート関連のコラム
